ISRCTN79217590已完成不适用
European Randomised Trial of Ovarian Cancer Screening II
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. All women aged 50-64 years
- •2. Before agreeing to join the trial, the women will have read the leaflet about the trial.
排除标准
- •1. Women already known to have ovarian cancer
- •2. Women who have had a bilateral oophorectomy
研究者
相似试验
已完成
不适用
Targeted screening for ovarian cancer in women over 50 years of age with vague presenting symptomsOvarian cancerMalignant neoplasm of ovaryCancerISRCTN04011070Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
进行中（未招募）
不适用
Phase II trial in platinum-refractory ovarian cancer: a randomized multicenter trial with SU11248 to evaluate dosage, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapyPlatinum refractory or resistant ovarian cancer, primary cancer of the peritoneum or fallopian tube (defined as stable (SD) or progressive disease (PD) during platinum containing chemotherapy, or treatment free interval < 6 months after stop of platinum based chemotherapy)EUCTR2007-003089-16-DEAGO Research GmbH72
已完成
不适用
A randomised trial in relapsed ovarian cancer, early treatment based on Cancer Antigen (CA) 125 levels alone versus delayed treatment based on conventional clinical factorsOvarianCancerISRCTN87786644Medical Research Council (MRC) (UK)1,400
已完成
不适用
orth Thames CA125 study in advanced ovarian cancerOvarian cancerCancerISRCTN75843298K Co-ordinating Committee for Cancer Research (UKCCCR)237
已完成
不适用
Sentinel node in ovarian cancermalignancy of the ovary10038594ovarian cancerNL-OMON37538Medisch Universitair Ziekenhuis Maastricht28